In the current paper, we present the results of Kazakh propolis investigations. Due to limited data about propolis from this country, research was focused mainly on phytochemical analysis and evaluation of propolis antimicrobial activity. uHPLC-DAD (ultra-high-pressure-liquid chromatography coupled with diode array detection, UV/VIS) and uHPLC-MS/MS (ultra-high-pressure-liquid chromatography coupled with tandem mass spectrometry) were used to phytochemical characteristics while antimicrobial activity was evaluated in the serial dilution method (MIC, minimal inhibitory concentration, and MBC/MFC, minimal bactericidal/fungicidal concentration measurements). In the study, Kazakh propolis exhibited a strong presence of markers characteristic of poplar-type propolis—flavonoid aglycones (pinocembrin, galangin, pinobanksin and pinobanskin-3-O-acetate) and hydroxycinnamic acid monoesters (mainly caffeic acid phenethyl ester and different isomers of caffeic acid prenyl ester). The second plant precursor of Kazakh propolis was aspen–poplar with 2-acetyl-1,3-di-p-coumaroyl glycerol as the main marker. Regarding antimicrobial activity, Kazakh propolis revealed stronger activity against reference Gram-positive strains (MIC from 31.3 to above 4000 mg/L) and yeasts (MIC from 62.5 to 1000 mg/L) than against reference Gram-negative strains (MIC ≥ 4000 mg/L). Moreover, Kazakh propolis showed good anti-Helicobacter pylori activity (MIC and MBC were from 31.3 to 62.5 mg/L). All propolis samples were also tested for H. pylori urease inhibitory activity (IC₅₀, half-maximal inhibitory concentration, ranged from 440.73 to 11,177.24 µg/mL). In summary Kazakh propolis are potent antimicrobial agents and may be considered as a medicament in the future.

Ziziphora species (Lamiaceae) have been used in traditional medicine as sedatives, antiseptics, carminatives, or expectorants. Despite their common applications in phytotherapy, there is still lack of evidence about the composition of their extracts and its impact on biological properties of the plants. The aim of this study was to evaluate the content of Ziziphora bungeana, a less studied species growing in Kazakhstan, using HPLC-ESI-QTOF-MS/MS instrumentation and to determine its antimicrobial, antioxidant, and cytotoxic activity together with inhibitory properties against tyrosinase and toxicity in erythrocyte lysis assay. Extracts from Z. bungeana were found to be sources of flavonoids, phenolic acids, organic acids, and terpenes that determined their antiradical activity. The minimum inhibitory concentrations of extracts were lower for Gram-positive bacteria (1.25–10 mg/mL) than for Gram-negative bacteria and fungi (5–20 mg/mL). The EC₅₀ value calculated for antiradical activity ranged between 15.00 ± 1.06 µg/mL and 13.21 ± 3.24 µg/mL for ABTS and DPPH assays, respectively. Z. bungeana extracts were found to decrease the activity of tyrosinase by 50% (at 200 µg/mL) similarly to kojic acid and were slightly cytotoxic for human melanoma A375 cell line (at 200 µg/mL) with no effect on HaCaT keratinocytes. In the end, Z. bungeana did not reveal toxic effects in hemolytic assay as compared to the positive control Triton X-100. The performed tests show potential application of the plant in the treatment of infectious diseases, disorders caused by free radicals, and skin problems.

Background/Objectives: The essential oils of Abies species possess a complex chemical composition and pronounced biological activity. However, comparative studies of interspecies differences and on the influence of extraction methods on their chemical profile and pharmacological properties are limited. Such data are necessary for identifying the most promising species and optimizing essential oil production technologies for pharmaceutical applications. The aim of this study was to comparatively evaluate the essential oils of seven Abies species obtained by steam distillation and to analyze the effects of three extraction methods on the chemical and biological characteristics of Abies sibirica L. oil. Methods: The essential oils of seven Abies species were isolated by steam distillation. For A. sibirica, supercritical CO₂ extraction and microwave-assisted steam distillation (MASD) were additionally used. Chemical composition was determined by GC-MS. Statistical analysis included ANOVA, PCA and hierarchical cluster modeling, and non-parametric tests. Antifungal activity was assessed against Candida albicans, and antiradical activity was assessed using densitometric analysis. Results: GC-MS analysis revealed significant differences in chemical composition between species and extraction methods. The main compounds were bornyl acetate, α-pinene, and camphene. ANOVA revealed significant differences in bornyl acetate and β-pinene content between species (p < 0.001) and methods (p < 0.01). PCA and clustering identified a bornyl acetate-rich chemotype (A. sibirica, A. grandis, A. lowiana). A. sibirica oil, obtained by MASD, exhibited high antifungal activity (82% inhibition), similar to that of 5-flucytosine (95%). Antiradical activity correlated with monoterpenes corresponding to peaks 2 and 7 of the densitogram. Conclusions: This study demonstrates that the species and extraction method significantly determine the chemical profile and biological properties of Abies oils. A. sibirica oil, obtained by MASD, demonstrated the highest activity, highlighting its potential as a source of biologically active compounds.

Background: The growing demand for safe and effective phytopharmaceuticals underscores the importance of studying regionally available medicinal plants. Acorus calamus L. and Calendula officinalis L., widely distributed in the Republic of Kazakhstan, are promising sources of biologically active compounds with significant pharmacological potential. However, the combined use of their CO₂ extracts remains insufficiently characterised, particularly regarding possible synergistic interactions. Therefore, the development of new dosage forms and their comprehensive pharmacological and toxicological evaluation is a priority in modern pharmaceutical research. Methods: Concentrated extracts from Acorus calamus rhizomes and Calendula officinalis flowers were obtained using precritical CO₂ extraction. Safety was assessed through acute and chronic toxicity studies in laboratory animals according to standard non-clinical guidelines. Animals received graded doses of the extracts and developed formulations (‘Exkair’ tablets and ‘Zerp-Ak-Broncho’ granules). Clinical condition, mortality, body weight, and behaviour were monitored. Biochemical, haematological, and histopathological analyses were performed. Antitussive activity was evaluated in vivo by measuring oedema inhibition relative to reference drugs. Results: The CO₂ extracts and formulations demonstrated low toxicity and good tolerability, with no mortality or significant adverse effects observed even at high doses. Biochemical and haematological parameters remained within physiological ranges, and histopathological examination revealed no structural alterations in internal organs. Both ‘Exkair’ and ‘Zerp-Ak-Broncho’ exhibited pronounced antitussive activity, confirmed by significant suppression of oedema. This effect is likely associated with the synergistic action of flavonoids, terpenoids, and phenolic compounds. Conclusions: The findings indicate that CO₂ extracts of Acorus calamus L. and Calendula officinalis L., as well as the developed formulations, possess a favourable safety profile and significant antitussive activity. These results support their further development as phytotherapeutic agents in Kazakhstan.

Abutilon theophrasti Medic. is a widely distributed species belonging to the Malvaceae family. It represents a potential source of bioactive compounds with antioxidant, anti-inflammatory, and antimicrobial properties. Despite the species’ pharmacological significance and its widespread distribution, information on the diagnostic pharmacognostic characteristics of A. theophrasti Medic. remains limited, and no such studies have previously been conducted on raw materials growing in Kazakhstan. The objective of this study was to ascertain the diagnostically significant morphological, anatomical, and histochemical characteristics of A. theophrasti Medic. in order to facilitate the identification and pharmacognostic standardization of medicinal plant raw materials. The subjects of the study were the plant’s aerial and underground organs, including leaves, stems, petioles, inflorescences, flowers, fruits, and roots. A comprehensive analysis of the raw material was conducted using a variety of analytical methods, including macroscopic, microscopic, and histochemical approaches. The study’s findings enabled the identification of characteristic features of the plant’s aerial and underground organs through macroscopic analysis. Microscopic examination revealed diagnostically significant characteristics of the species A. theophrasti Medic., including an anomocytic stomatal apparatus, numerous simple and stellate trichomes, calcium oxalate druses, and characteristic anatomical features of the leaf, stem, sepals, and root. Taken together, these characteristics form a diagnostic complex that can be used to identify this species. Histochemical analysis revealed the localization of phenolic compounds, flavonoids, and trace amounts of essential oil in the tissues of the leaf petiole and root. However, alkaloids, starch, and sesquiterpene lactones were not detected. The identified morphological, anatomical, and histochemical data serve to supplement the information on the diagnostically significant characteristics of the species, carrying practical importance for the quality assessment of plant raw materials.

The genus Abutilon (Malvaceae) comprises taxonomically and phytochemically diverse medicinal plants with a long history of ethnomedicinal use. This critical narrative review integrates evidence on the taxonomy, traditional applications, phytochemical composition, pharmacological activities, molecular mechanisms, safety, and pharmaceutical potential of Abutilon species, incorporating the literature published through September 2026. Flavonoids, phenolic acids, triterpenoids, phytosterols, polysaccharides, and fatty acids represent major reported constituent classes, although the reliability of their identification and quantitative characterization varies among studies. A. indicum and A. theophrasti remain the most extensively investigated species. Experimental findings support preliminary antioxidant, anti-inflammatory, antimicrobial, antidiabetic, hepatoprotective, gastroprotective, and other biological activities, predominantly in biochemical, cellular, and animal models. Mechanistic investigations have reported modulation of NF-κB/MAPK signaling, inflammatory mediators, glucose-regulatory processes, and oxidative stress-related responses; however, direct molecular target validation remains limited. Pharmaceutical studies have explored tablets, phytosomal formulations, and plant-mediated nanoparticles, but evidence of improved systemic bioavailability, therapeutic efficacy, and long-term safety remains insufficient. Toxicological findings indicate preparation- and dose-dependent responses, while controlled clinical evidence is extremely limited. Methodological heterogeneity, incomplete chemical standardization, and limited pharmacokinetic characterization further restrict cross-study comparisons and therapeutic translation. Future research should prioritize authenticated botanical materials, chemically standardized preparations, reproducible dose–response studies, direct mechanistic validation, comprehensive toxicological assessment, and appropriately designed clinical investigations. Overall, Abutilon represents a potentially valuable source of pharmacologically active natural products, but current evidence does not establish standardized clinical applications.